These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 6806365
41. Human bifunctional antibody generated by heterologous association of heavy and light chains. Tachibana H, Shirahata S, Murakami H. Hum Antibodies Hybridomas; 1993 Apr; 4(2):42-6. PubMed ID: 8518364 [Abstract] [Full Text] [Related]
42. Strategies in the development of human monoclonal antibodies. Jahn S, Grunow R, Kiessig ST, Settmacher U, Von Baehr R. Dev Biol Stand; 1990 Apr; 71():3-7. PubMed ID: 2401386 [Abstract] [Full Text] [Related]
43. Ig biosynthesis in a human pre-B cell line. McCune JM, Fu SM. J Immunol; 1981 Dec; 127(6):2609-11. PubMed ID: 6271874 [Abstract] [Full Text] [Related]
44. Hybridomas secreting monoclonal antibody with specificity for Toxoplasma gondii. Sethi KK, Endo T, Brandis H. J Parasitol; 1980 Apr; 66(2):192-6. PubMed ID: 7391860 [Abstract] [Full Text] [Related]
45. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells. Hagner G. Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367 [Abstract] [Full Text] [Related]
46. High frequency of loss of human kappa light chain expression in mouse-human heterohybridomas. Uchiyama K, Saito H, Tokuhisa T, Imai K, Taniguchi M. Hybridoma; 1987 Dec; 6(6):645-54. PubMed ID: 3125100 [Abstract] [Full Text] [Related]
48. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, Schramm SR, Kuo CC, Mashayekh R, Wymore K, McCabe JG. Nature; 1994 Apr 28; 368(6474):856-9. PubMed ID: 8159246 [Abstract] [Full Text] [Related]
49. Somatic cell hybrids of mouse myeloma cells and B lymphocytes from a patient with agammaglobulinemia: failure to secrete human immunoglobulin. Schwaber JF, Rosen FS. J Immunol; 1979 May 28; 122(5):1849-54. PubMed ID: 109516 [Abstract] [Full Text] [Related]
50. Comparative study of the N-glycans of human monoclonal immunoglobulins M produced by hybridoma and parental cells. Fukuta K, Abe R, Yokomatsu T, Kono N, Nagatomi Y, Asanagi M, Shimazaki Y, Makino T. Arch Biochem Biophys; 2000 Jun 01; 378(1):142-50. PubMed ID: 10871054 [Abstract] [Full Text] [Related]
51. Kinetics of human light chain synthesis by human-mouse myeloma hybrids. Cieplinski W, Wardwell J, Schwink AM. Cancer Biochem Biophys; 1983 Dec 01; 7(1):1-10. PubMed ID: 6421474 [Abstract] [Full Text] [Related]
52. Production and immunoselection of IgM-IgA hybridomas: preparing immunoglobulins with dual binding specificity. Ju ST, Strack P, Dorf ME. Mol Immunol; 1989 Mar 01; 26(3):283-92. PubMed ID: 2495437 [Abstract] [Full Text] [Related]
55. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells. Li M, Cortez S, Nakamachi T, Batuman V, Arimura A. Cancer Res; 2006 Sep 01; 66(17):8796-803. PubMed ID: 16951196 [Abstract] [Full Text] [Related]